10-Q 1 form10-q.htm
false Q3 --12-31 0001888734 0001888734 2023-01-01 2023-09-30 0001888734 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001888734 GLLI:WarrantsMember 2023-01-01 2023-09-30 0001888734 us-gaap:RightsMember 2023-01-01 2023-09-30 0001888734 GLLI:UnitsMember 2023-01-01 2023-09-30 0001888734 2023-11-13 0001888734 2023-09-30 0001888734 2022-12-31 0001888734 2023-07-01 2023-09-30 0001888734 2022-07-01 2022-09-30 0001888734 2022-01-01 2022-09-30 0001888734 GLLI:RedeemableCommonStockMember 2023-07-01 2023-09-30 0001888734 GLLI:RedeemableCommonStockMember 2022-07-01 2022-09-30 0001888734 GLLI:RedeemableCommonStockMember 2023-01-01 2023-09-30 0001888734 GLLI:RedeemableCommonStockMember 2022-01-01 2022-09-30 0001888734 GLLI:NonRedeemableCommonStockMember 2023-07-01 2023-09-30 0001888734 GLLI:NonRedeemableCommonStockMember 2022-07-01 2022-09-30 0001888734 GLLI:NonRedeemableCommonStockMember 2023-01-01 2023-09-30 0001888734 GLLI:NonRedeemableCommonStockMember 2022-01-01 2022-09-30 0001888734 us-gaap:CommonStockMember 2022-12-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001888734 us-gaap:RetainedEarningsMember 2022-12-31 0001888734 us-gaap:CommonStockMember 2023-03-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001888734 us-gaap:RetainedEarningsMember 2023-03-31 0001888734 2023-03-31 0001888734 us-gaap:CommonStockMember 2023-06-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001888734 us-gaap:RetainedEarningsMember 2023-06-30 0001888734 2023-06-30 0001888734 us-gaap:CommonStockMember 2021-12-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001888734 us-gaap:RetainedEarningsMember 2021-12-31 0001888734 2021-12-31 0001888734 us-gaap:CommonStockMember 2022-03-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001888734 us-gaap:RetainedEarningsMember 2022-03-31 0001888734 2022-03-31 0001888734 us-gaap:CommonStockMember 2022-06-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001888734 us-gaap:RetainedEarningsMember 2022-06-30 0001888734 2022-06-30 0001888734 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001888734 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001888734 2023-01-01 2023-03-31 0001888734 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001888734 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001888734 2023-04-01 2023-06-30 0001888734 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001888734 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001888734 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001888734 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001888734 2022-01-01 2022-03-31 0001888734 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001888734 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001888734 2022-04-01 2022-06-30 0001888734 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001888734 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001888734 us-gaap:CommonStockMember 2023-09-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001888734 us-gaap:RetainedEarningsMember 2023-09-30 0001888734 us-gaap:CommonStockMember 2022-09-30 0001888734 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001888734 us-gaap:RetainedEarningsMember 2022-09-30 0001888734 2022-09-30 0001888734 us-gaap:IPOMember 2021-12-07 2021-12-09 0001888734 us-gaap:IPOMember 2021-12-09 0001888734 GLLI:PrivatePlacementUnitsMember 2021-12-07 2021-12-09 0001888734 GLLI:PrivatePlacementUnitsMember 2021-12-09 0001888734 us-gaap:OverAllotmentOptionMember 2021-12-11 2021-12-13 0001888734 GLLI:PrivatePlacementUnitsMember 2021-12-11 2021-12-13 0001888734 GLLI:PrivatePlacementUnitsMember 2021-12-13 0001888734 us-gaap:OverAllotmentOptionMember 2021-12-13 2021-12-13 0001888734 us-gaap:IPOMember 2021-12-11 2021-12-13 0001888734 us-gaap:IPOMember 2021-12-13 0001888734 GLLI:PublicShareMember 2023-09-30 0001888734 GLLI:PublicShareMember 2023-01-01 2023-09-30 0001888734 us-gaap:IPOMember 2023-03-09 2023-03-09 0001888734 us-gaap:IPOMember 2023-03-09 0001888734 GLLI:PublicGoldMarketingMember 2023-09-09 0001888734 2023-09-09 0001888734 us-gaap:SubsequentEventMember 2023-10-04 0001888734 us-gaap:SubsequentEventMember 2023-10-31 0001888734 GLLI:PublicGoldMarketingMember 2023-09-09 2023-09-09 0001888734 GLLI:PublicGoldMarketingMember 2023-10-04 2023-10-04 0001888734 us-gaap:IPOMember 2023-01-01 2023-09-30 0001888734 2023-03-02 2023-03-06 0001888734 2023-03-06 0001888734 2023-03-06 2023-03-06 0001888734 GLLI:PublicWarrantsAndPrivatePlacementWarrantsMember 2021-12-09 0001888734 GLLI:PublicWarrantsAndPrivatePlacementWarrantsMember 2023-01-01 2023-09-30 0001888734 GLLI:PublicWarrantsAndPrivatePlacementWarrantsMember 2022-01-01 2022-09-30 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2022-01-01 2022-12-31 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2022-12-31 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-01-01 2023-03-31 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-03-31 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-04-01 2023-06-30 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-06-30 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-07-01 2023-09-30 0001888734 us-gaap:CommonStockSubjectToMandatoryRedemptionMember 2023-09-30 0001888734 srt:ScenarioPreviouslyReportedMember GLLI:RedeemableMember 2023-07-01 2023-09-30 0001888734 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember GLLI:RedeemableMember 2023-07-01 2023-09-30 0001888734 GLLI:RedeemableMember 2023-07-01 2023-09-30 0001888734 srt:ScenarioPreviouslyReportedMember GLLI:NonRedeemableMember 2023-07-01 2023-09-30 0001888734 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember GLLI:NonRedeemableMember 2023-07-01 2023-09-30 0001888734 GLLI:NonRedeemableMember 2023-07-01 2023-09-30 0001888734 srt:ScenarioPreviouslyReportedMember GLLI:RedeemableMember 2023-01-01 2023-09-30 0001888734 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember GLLI:RedeemableMember 2023-01-01 2023-09-30 0001888734 GLLI:RedeemableMember 2023-01-01 2023-09-30 0001888734 srt:ScenarioPreviouslyReportedMember GLLI:NonRedeemableMember 2023-01-01 2023-09-30 0001888734 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember GLLI:NonRedeemableMember 2023-01-01 2023-09-30 0001888734 GLLI:NonRedeemableMember 2023-01-01 2023-09-30 0001888734 GLLI:RedeemableCommonStockMember srt:RestatementAdjustmentMember 2023-07-01 2023-09-30 0001888734 GLLI:NonRedeemableCommonStockMember srt:RestatementAdjustmentMember 2023-07-01 2023-09-30 0001888734 GLLI:RedeemableCommonStockMember srt:RestatementAdjustmentMember 2022-07-01 2022-09-30 0001888734 GLLI:NonRedeemableCommonStockMember srt:RestatementAdjustmentMember 2022-07-01 2022-09-30 0001888734 GLLI:RedeemableCommonStockMember srt:RestatementAdjustmentMember 2023-01-01 2023-09-30 0001888734 GLLI:NonRedeemableCommonStockMember srt:RestatementAdjustmentMember 2023-01-01 2023-09-30 0001888734 GLLI:RedeemableCommonStockMember srt:RestatementAdjustmentMember 2022-01-01 2022-09-30 0001888734 GLLI:NonRedeemableCommonStockMember srt:RestatementAdjustmentMember 2022-01-01 2022-09-30 0001888734 us-gaap:IPOMember 2021-12-01 2021-12-31 0001888734 us-gaap:IPOMember 2021-12-31 0001888734 us-gaap:PrivatePlacementMember 2021-12-13 2021-12-13 0001888734 us-gaap:PrivatePlacementMember 2021-12-13 0001888734 GLLI:FounderSharesMember 2021-08-18 2021-08-19 0001888734 GLLI:FounderSharesMember 2021-08-19 0001888734 GLLI:WorkingCapitalLoansMember us-gaap:RelatedPartyMember 2023-09-30 0001888734 GLLI:WorkingCapitalLoansMember 2023-09-30 0001888734 GLLI:WorkingCapitalLoansMember us-gaap:RelatedPartyMember 2022-12-31 0001888734 GLLI:SponsorMember 2023-01-01 2023-09-30 0001888734 2023-09-04 2023-09-05 0001888734 2023-09-28 2023-09-29 0001888734 us-gaap:OverAllotmentOptionMember 2023-09-30 0001888734 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001888734 GLLI:PromissoryNote1Member 2023-03-01 2023-03-03 0001888734 GLLI:PromissoryNote1Member 2023-03-03 0001888734 GLLI:PromissoryNote1Member 2023-09-30 0001888734 GLLI:PromissoryNote2Member 2023-03-22 2023-03-23 0001888734 GLLI:PromissoryNote2Member 2023-03-23 0001888734 GLLI:PromissoryNote2Member 2023-09-30 0001888734 GLLI:PromissoryNote3Member 2023-06-01 2023-06-02 0001888734 GLLI:PromissoryNote3Member 2023-06-02 0001888734 GLLI:PromissoryNote3Member 2023-09-30 0001888734 GLLI:PromissoryNote1Member 2023-07-01 2023-09-30 0001888734 GLLI:PromissoryNote1Member 2023-01-01 2023-09-30 0001888734 GLLI:PublicWarrantsMember 2023-09-30 0001888734 GLLI:PublicWarrantsMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember 2022-12-31 0001888734 us-gaap:WarrantMember 2023-09-30 0001888734 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001888734 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001888734 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001888734 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001888734 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001888734 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001888734 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001888734 GLLI:PrivateWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-12-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-01-01 2023-03-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-03-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-04-01 2023-06-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-06-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-07-01 2023-09-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2023-09-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2021-12-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-01-01 2022-03-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-03-31 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-04-01 2022-06-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-06-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-07-01 2022-09-30 0001888734 GLLI:PrivatePlacementWarrantsMember 2022-09-30 0001888734 us-gaap:SubsequentEventMember 2023-10-05 2023-10-05 0001888734 GLLI:PromissoryNoteMember us-gaap:SubsequentEventMember 2023-10-13 0001888734 srt:ScenarioForecastMember 2023-11-30 2023-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                 to                 

 

Commission File No. 001-41122

 

GLOBALINK INVESTMENT INC.

(Exact name of registrant as specified in its charter)

 

Delaware   36-4984573

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

200 Continental Drive, Suite 401

Newark, Delaware, 19713

(Address of Principal Executive Offices, including zip code)

 

(212) 382-4605

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   GLLI   The Nasdaq Stock Market LLC
Warrants   GLLIW   The Nasdaq Stock Market LLC
Rights   GLLIR   The Nasdaq Stock Market LLC
Units   GLLIU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

 

As of November 13, 2023, there were 8,188,305 shares of common stock, par value $0.001 per share, issued and outstanding.

 

 

 

 
 

 

GLOBALINK INVESTMENT INC.

TABLE OF CONTENTS

 

      Page
PART 1 – FINANCIAL INFORMATION    
       
Item 1. Financial Statements   1
       
  Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2023 and December 31, 2022   1
       
  Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2023 and 2022   2
       
  Condensed Consolidated Statements of Changes in Stockholder’s Deficit (Unaudited) for the three and nine months ended September 30, 2023 and 2022   3
       
  Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2023 and 2022   4
       
  Notes to Condensed Consolidated Financial Statements (Unaudited)   5
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   18
       
Item 3. Quantitative and Qualitative Disclosures about Market Risk   24
       
Item 4. Controls and Procedures   24
       
PART II – OTHER INFORMATION    
       
Item 1. Legal Proceedings   24
       
Item 1A. Risk Factors   24
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   24
       
Item 3. Defaults Upon Senior Securities   24
       
Item 4. Mine Safety Disclosures   24
       
Item 5. Other Information   24
       
Item 6. Exhibits   25
       
SIGNATURES   26

 

i
 

 

Item 1. Interim Financial Statements (unaudited)

 

GLOBALINK INVESTMENT INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30, 2023   December 31, 2022 
    (Unaudited)      
ASSETS          
CURRENT ASSETS          
Cash and cash in escrow account  $137,073   $81,763 
Prepaid expenses – current   59,918    207,445 
Total current assets   196,991    289,208 
Cash and investments held in Trust Account   51,409,210    118,408,969 
TOTAL ASSETS  $51,606,201   $118,698,177 
           
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT          
CURRENT LIABILITIES          
Accounts payable  $28,183   $184,130 
Franchise tax payable   150,000    236,365 
Income tax payable   426,710    228,827 
Promissory note   1,373,376     
Due to affiliate   477,000    127,000 
Excise tax liability   699,209     
Total current liabilities   3,154,478    776,322 
Deferred tax liability       79,358 
Warrant liabilities   10,716    6,270 
Deferred underwriting fee payable   4,025,000    4,025,000 
Total Liabilities   7,190,194    4,886,950 
           
COMMITMENTS AND CONTINGENCIES   -    - 
REDEEMABLE COMMON STOCK          
           
Common stock subject to possible redemption, $0.001 par value, 4,743,305 and 11,500,000 shares at redemption value at September 30, 2023 and December 31, 2022 of $10.72 and $10.25 per share, respectively   50,832,500    117,864,419 
           
STOCKHOLDERS’ DEFICIT          
Common stock, $0.001 par value; 500,000,000 shares authorized; 3,445,000 shares issued and outstanding at September 30, 2023 and December 31, 2022 (excluding 4,743,305 and 11,500,000 shares subject to possible redemption)   3,445    3,445 
Accumulated deficit   (6,419,938)   (4,056,637)
Total Stockholders’ Deficit   (6,416,493)   (4,053,192)
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT  $51,606,201   $118,698,177 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

1
 

 

GLOBALINK INVESTMENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

   2023   2022   2023   2022 
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2023   2022   2023   2022 
OPERATING EXPENSES                    
General and administrative  $259,829   $580,823   $715,665   $824,303 
Franchise tax expense   50,000    50,000    133,956    150,000 
Total operating expenses    309,829    630,823    849,621    974,303 
                     
Other income (expense):                    
Income on cash and investments held in Trust Account   621,793    608,230    2,550,909    696,468 
Penalties on income tax   (11,888)       (11,888)    
Interest expense   (20,265)       (33,376)    
Change in fair value of warrant liabilities   1,824    (9,462)   (4,446)   80,370 
Total other income, net   591,464    598,768    2,501,199    776,838 
                     
Income (loss) before provision for income taxes   281,635    (32,055)   1,651,578    (197,465)
Provision for income taxes   (27,338)   (97,086)   (426,710)   (97,086)
Net income (loss)  $254,297   $(129,141)  $1,224,868   $(294,551)
                     
Weighted average shares outstanding Common stock-redeemable   4,743,305    11,500,000    6,352,042    11,500,000 
Basic and diluted net income (loss) per share, Common stock-redeemable  $0.09   $(0.00)  $0.28   $(0.01)
                     
Weighted average shares outstanding Common stock-non redeemable   3,445,000    3,445,000    3,445,000    3,445,000 
Basic and diluted net loss per share, Common stock-non-redeemable  $(0.05)  $(0.03)  $(0.17)  $(0.04)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

2
 

 

GLOBALINK INVESTMENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023

 

   Shares   Amount   deficit   deficit 
   Common stock   Accumulated  

Total

stockholders’

 
   Shares   Amount   deficit   deficit 
                 
Balance, December 31, 2022   3,445,000   $3,445 - $(4,056,637)  $(4,053,192)
Remeasurement of shares subject to possible redemption        -  (1,343,926)   (1,343,926)
Excise tax imposed on common stock redemptions        -  (699,209)   (699,209)
Net income        -  682,939    682,939 
Balance, March 31, 2023   3,445,000    3,445 -  (5,416,833)   (5,413,388)
Remeasurement of shares subject to possible redemption        -  (882,468)   (882,468)
Net income        -  287,632    287,632 
Balance, June 30, 2023   3,445,000    3,445 -  (6,011,669)   (6,008,224)
Remeasurement of shares subject to possible redemption        -  (662,566)   (662,566)
Net income        -  254,297    254,297 
Balance, September 30, 2023   3,445,000   $3,445 - $(6,419,938)  $(6,416,493)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

 

   Shares   Amount   capital   deficit   deficit 
   Common stock  

Additional

paid-in

   Accumulated   Total stockholders’ 
   Shares   Amount   capital   deficit   deficit 
                     
Balance, December 31, 2021   3,445,000   $3,445   $   $(3,141,460)  $(3,138,015)
Net loss                      (154,893)      (154,893)
Balance, March 31, 2022   3,445,000    3,445        (3,296,353)   (3,292,908)
Net loss                (10,517)   (10,517)
Balance, June 30, 2022   3,445,000    3,445        (3,306,870)   (3,303,425)
Remeasurement of shares subject to possible redemption, net of $331,340 in trust funds that may be used to pay tax liabilities               (365,227)   (365,227)
Net loss               (129,141)   (129,141)
Balance, September 30, 2022   3,445,000   $3,445    -   $(3,801,238)  $(3,797,793)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

3
 

 

GLOBALINK INVESTMENT INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   2023   2022 
  

For the Nine Months Ended

September 30,

 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $1,224,868   $(294,551)
Adjustments to reconcile net income to net cash used in operating activities:          
Interest on cash and investments held in Trust Account   (2,550,909)   (696,468)
Change in fair value of warrant liabilities   4,446    (80,370)
Changes in operating assets and liabilities:          
Prepaid expenses   147,527    150,162 
Deferred tax liability   (79,358)    
Due to affiliate   90,000    90,000 
Income tax payable   197,883    97,086 
Interest expense accrual   33,376     
Accounts payable   (155,946)   98,081 
Franchise tax payable   (86,365)   150,000 
Net cash used in operating activities   (1,174,478)   (486,060)
           
Cash Flows from Investing Activities:          
Cash withdrawn from Trust Account to pay tax obligations   539,788     
Cash withdrawn from Trust Account in connection with redemption of common stock   69,920,879     
Cash deposited to Trust Account for extension   (910,000)    
Net cash provided by investing activities   69,550,667     
           
Cash Flows from Financing Activities:          
Proceeds from promissory note   1,340,000     
Due to affiliate- advance   260,000     
Common stock redemption   (69,920,879)    
Net cash used in financing activities   (68,320,879)    
           
NET CHANGE IN CASH   55,310    (486,060)
CASH, BEGINNING OF PERIOD   81,763    812,232 
CASH, END OF PERIOD  $137,073   $326,172 
           
Supplementary cash flow information:          
Cash paid for income taxes  $308,285   $ 
           
Non-Cash investing and financing activities:          
Excise tax accrued for common stock redemptions  $699,209   $ 
Remeasurement of common stock subject to redemption  $2,888,960   $365,227 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

4
 

 

GLOBALINK INVESTMENT INC

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2023

 

Note 1 – Description of Organization and Business Operations and Liquidity

 

Globalink Investment Inc. (the “Company”) was incorporated in Delaware on March 24, 2021. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”). On July 27, 2022, Globalink Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary of Globalink, was formed.

 

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation and Initial Public Offering (“IPO”), which is described below and, since the offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO. The registration statement for the Company’s IPO was declared effective on December 6, 2021. On December 9, 2021, the Company consummated the IPO of 10,000,000 units (“Units”) at $10.00 per Unit generating gross proceeds of $100,000,000, which is discussed in Note 3. The Company has selected December 31 as its fiscal year end.

 

Simultaneously with the closing of the IPO, the Company consummated the sale of 517,500 units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to Public Gold Marketing Sdn. Bhd, a Malaysian private limited company, an entity not affiliated with the Company, the sponsor or the underwriters, generating gross proceeds of $5,175,000, which is described in Note 4.

 

Additionally with the closing of the IPO, the Company granted the underwriters a 45-day option to purchase up to 1,500,000 Units to cover over-allotment. On December 13, 2021, the underwriters fully exercised the option and purchased 1,500,000 additional Units (the “Over-allotment Units”), generating additional gross proceeds of $15,000,000.

 

Simultaneously with the exercise of the over-allotment, the Company consummated a private sale of an additional 52,500 Private Placement Units to Public Gold Marketing Sdn. Bhd at a price of $10.00 per Private Placement Unit, generating additional gross proceeds of $525,000. Since the underwriters’ over-allotment was exercised in full, the sponsor did not forfeit any Founder Shares (as defined in Note 5).

 

Offering costs for the IPO and the exercise of the underwriters’ over-allotment option amounted to $6,887,896, consisting of $2,300,000 of underwriting fees, $4,025,000 of deferred underwriting fees payable (which are held in the Trust Account (defined below)) and $562,896 of other costs. As described in Note 6, the $4,025,000 of deferred underwriting fee payable is contingent upon the consummation of a Business Combination, subject to the terms of the underwriting agreement.

 

Following the closing of the IPO, $116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a trust account (“Trust Account”) and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act.

 

To mitigate the risk of being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), on August 9, 2023, the Company instructed Continental Stock Transfer & Trust Company, the trustee of the Trust Account (the “Trustee” or “Continental”), to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (which may include demand deposit accounts) until the earlier of consummation of our Business Combination or liquidation. Furthermore, such cash is held in bank accounts, which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation (the “FDIC”).

 

5
 

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account excluding the deferred underwriting discounts and taxes payable on income earned on the Trust Account at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect a Business Combination.

 

The Company will provide the holders (the “Public Stockholders”) of the outstanding shares of common stock included in the Units, or the Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.15 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights with respect to the Company’s warrants.

 

All of the Public Shares contain a redemption feature, which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480-10-S99, redemption provisions not solely within the control of a company require the Public Shares subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants and rights), the initial carrying value of common stock classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Public Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the consolidated balance sheets until such date that a redemption event takes place.

 

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

 

6
 

 

Notwithstanding the foregoing, the amended and restated certificate of incorporation of the Company (the “Certificate of Incorporation”) provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the shares of common stock sold in the IPO, without the prior consent of the Company.

 

The Company’s sponsor, officers and directors (the “Initial Stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of common stock in conjunction with any such amendment.

 

The Company originally had until March 9, 2023, 15 months from the closing of the IPO to complete a Business Combination. On March 6, 2023, the Company held a special meeting (the “Special Meeting”), during which the stockholders of the Company approved a proposal to amend the Company’s amended and restated certified articles of incorporation which included extending the time in which the Company must complete a Business Combination (the “Extension Amendment Proposal”) and a proposal to amend the Company’s investment management trust agreement, dated as of December 6, 2021 (the “Trust Agreement”), by and between the Company and Continental (the “Trust Amendment Proposal”). The Company will have the option of two (2) three-months extensions, followed by three (3) one-month extensions, or until December 9, 2023, if all extensions are exercised. The Company exercised the option for two three-month extensions and as a result the Company has deposited a total of $780,000, or $390,000 for each three-month extension, into the Trust Account and had until September 9, 2023 to complete its Business Combination, which was funded by the promissory note with Public Gold Marketing Sdn Bhd which has a current balance of $1,373,376. On September 9, 2023, October 4, 2023, and October 31, 2023, the Company deposited $130,000 each time into the Trust Account, representing $0.0275 per public share, which further extended the period of time it has to consummate its initial business combination to December 9, 2023 (“Combination Period”). The September 9, 2023 and October 4, 2023 payments were funded by the advance of $260,000 provided by an affiliate of the sponsor. The Company has exhausted the five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company currently in effect. If the Company does not complete its Business Combination or exercise an additional extension, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to us to pay the Company’s franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish the Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

 

On March 6, 2023, in connection with the approval of the Extension Amendment Proposal and the Trust Amendment Proposal at the Special Meeting which extended the time in which the Company must complete a Business Combination, holders of 6,756,695 of the Company’s shares of common stock exercised their right to redeem those shares for cash at an approximate price of $10.35 per share, for an aggregate of approximately $69.92 million.

 

The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire any Public Shares in or after the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to deferred underwriting discounts (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.15 per share held in the Trust Account. In order to protect the amounts held in the Trust Account, the sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Business Combination

 

On August 3, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among Tomorrow Crypto Group Inc., a Nevada corporation (“Tomorrow Crypto”), Globalink Merger Sub, Inc., a Nevada corporation and a wholly-owned subsidiary of Globalink (“Merger Sub”), GL Sponsor LLC, a Delaware limited liability company

 

In accordance with the termination provisions under Section 10.1 of the Merger Agreement, the Merger Agreement was terminated on March 8, 2023 (the “Merger Agreement Termination Date”). In conjunction with the termination of the Merger Agreement, the Additional Agreements (as defined in the Merger Agreement) (including the Support Agreements) were also terminated in accordance with their respective terms as of March 8, 2023, the Merger Agreement Termination Date.

 

Risks and Uncertainties

 

We continue to evaluate the impact of increases in inflation and rising interest rates, financial market instability, including the recent bank failures, the potential government shutdown, the lingering effects of the COVID-19 pandemic and certain geopolitical events, including the wars in Ukraine and the surrounding region and between Israel and Hamas. We have concluded that while it is reasonably possible that the risks and uncertainties related to or resulting from these events could have a negative effect on our financial position, results of operations and/or ability to complete an initial Business Combination, we cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact our business and our ability to complete an initial Business Combination.

 

7
 

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

 

Liquidity, Capital Resources and Going Concern

 

As of September 30, 2023, the Company had $137,073 of cash held in escrow which is available to meet working capital needs and a working capital deficit of approximately $2.96 million.

 

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company will need to raise additional capital through loans or additional investments from its sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and the sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing.

 

If the Business Combination is not consummated, the Company will need to raise additional capital through loans or additional investments from its sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and its sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

 

In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 9, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension is not requested by the Company’s sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur and an extension is not requested by the Company’s sponsor, and potential subsequent dissolution as well as liquidity condition noted above raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 9, 2023.

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in unaudited condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as filed with the SEC on April 17, 2023. The interim results for the three and nine months ended September 30, 2023 presented are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

 

8
 

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Emerging Growth Company

 

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these consolidated unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events.

 

Cash and cash held in escrow

 

The Company had $0 and $81,763 held in escrow on September 30, 2023 and December 31, 2022, respectively. During the three months ended September 30, 2023 the Company transferred the cash amount held in escrow to a newly opened bank account.

 

Cash and investments Held in Trust Account

 

As of December 31, 2022, substantially all of the assets held in the Trust Account were held in money market funds. Assets held in money market funds were invested primarily in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on investments held in Trust Account in the accompanying unaudited condensed consolidated statements of operations.

 

To mitigate the risk of being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), on August 9, 2023, the Company instructed the Trustee of the Trust Account, to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (which may include demand deposit accounts) until the earlier of consummation of our Business Combination or liquidation. Furthermore, such cash is held in bank accounts, which exceed federally insured limits as guaranteed by the FDIC.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit. As of September 30, 2023 and December 31, 2022, the Company had not experienced losses on these accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” approximate the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.

 

Income Taxes

 

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of September 30, 2023 and December 31, 2022, the Company’s deferred tax asset for start up organizational expenses had a full valuation allowance recorded against it.

 

9
 

 

While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income (loss) and associated income tax provision based on actual results through September 30, 2023. The Company’s effective tax rate was 9.71% and (302.87)% for the three months ended September 30, 2023 and 2022, respectively, and 25.84% and (49.17)% for the nine months ended September 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and nine months ended September 30, 2023 and 2022, primarily due to changes in the fair value in warrant liabilities, valuation allowance on the deferred tax assets, non-deductible M&A costs, income tax penalties, and failed deal costs that are fully deductible.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2023 or December 31, 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three months ended September 30, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 

Excise Tax

 

In connection with the vote to approve the Charter Amendment Proposal, holders of 6,756,695 shares of common stock properly exercised their right to redeem their shares of common stock for an aggregate redemption amount of approximately $69,920,079. As such, the Company has recorded a 1% excise tax liability in the amount of $699,209 on the unaudited condensed consolidated balance sheet as of September 30, 2023. The liability does not impact the unaudited condensed consolidated statements of operations and is offset against additional paid-in capital or accumulated deficit if additional paid-in capital is not available. This excise tax liability can be offset by future share issuances within the same fiscal year which will be evaluated and adjusted in the period in which the issuances occur. Should the Company liquidate prior to December 31, 2023, the excise tax liability will not be due.

 

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s shares of common stock sold in the IPO and as a result of the exercise by the underwriters of their over-allotment option features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, on September 30, 2023 and December 31, 2022, 4,743,305 and 11,500,000 shares of common stock subject to possible redemption were presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed consolidated balance sheets.

 

On March 6, 2023, in connection with the approval of the Extension Amendment Proposal and the Trust Amendment Proposal at the Special Meeting, holders of 6,756,695 of the Company’s shares of common stock exercised their right to redeem those shares for cash at an approximate price of $10.35 per share, for an aggregate of approximately $69.92 million.

 

As of September 30, 2023 and December 31, 2022, the shares of common stock subject to possible redemption reflected in the condensed consolidated balance sheets is reconciled in the following table:

 

Gross proceeds  $115,000,000 
Less:     
Proceeds allocated to Public Warrants   (10,465,000)
Common stock issuance costs   (6,236,933)
Plus:     
Remeasurement of carrying amount to redemption value   19,566,352 
Common stock subject to possible redemption, December 31, 2022   117,864,419 
Less:     
Redemptions (paid in April 2023)   (69,920,879)
Plus:     
Remeasurement of carrying value to redemption value   1,343,926 
Common stock subject to possible redemption, March 31, 2023   49,287,466 
Plus:     
Remeasurement of carrying value to redemption value   882,468 
Common stock subject to possible redemption, June 30, 2023   50,169,934 
Plus:     
Remeasurement of carrying value to redemption value   662,566 
Common stock subject to possible redemption, September 30, 2023  $50,832,500 

 

10
 

 

Net Income (Loss) Per Share of Common Stock

 

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share” and uses the two class method. Net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. Any remeasurement of the accretion to redemption value of the shares of common stock subject to possible redemption was considered to be dividends paid to the public stockholders.

 

The Company has one authorized class of common stock. Warrants included in the Units sold in the IPO (the “Public Warrants”) (see Note 3) and warrants included in the Private Placement Units (the “Private Placement Warrants,” together with the Public Warrants, the “warrants”) (see Note 4) to purchase 7,242,000 shares of common stock of the Company at $10.00 per share were issued on December 9, 2021. For the three and nine months ended September 30, 2023 and 2022, no Public Warrants or Private Placement Warrants had been exercised. The 7,242,000 potential shares of common stock underlying the outstanding Public Warrants and Private Placement Warrants to purchase the Company’s shares of common stock were excluded from diluted earnings (losses) per share for the periods ended September 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. Additionally, the rights are able to be demanded on or any time after the Business Combination, and as the contingency has not been met, the rights are excluded from diluted earnings (loss) per share for the periods ended September 30, 2023 and 2022. As a result, diluted net income (loss) per share of common stock is the same as basic net income (loss) per share of common stock for the periods. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of stock.

 

Revision of Prior Year Net Loss Per Share of Common Stock

 

In the Form 10-Q for three and nine months ended September 30, 2022, the Company discovered an error in the earnings per share calculation. The Company excluded the remeasurement of the accretion to redemption value of the shares of common stock subject to possible redemption. To correct this, the Company has revised its prior period earnings per share calculation in these condensed consolidated financial statements. The impact of the change is summarized below:

 

For the three months ended September 30, 2022 

 

   As Filed   Adjustment   As Revised 
Redeemable  $(0.01)  $0.01   $0.00 
Non-Redeemable  $(0.01)  $(0.02)  $(0.03)

 

For the nine months ended September 30, 2022

 

   As Filed   Adjustment   As Revised 
Redeemable  $(0.02)  $0.01   $(0.01)
Non-Redeemable  $(0.02)  $(0.02)  $(0.04)

 

The following table reflects the calculation of basic and diluted net income (loss) per share of common stock (in dollars, except per share amounts):

   2023   2022 
   For the Three Months Ended September 30, 
   2023   2022 
Net income (loss)  $254,297   $(129,141)
Remeasurement of common stock subject to redemption   (662,566)   (365,227)
Net income (loss) including remeasurement of common stock subject to redemption value  $(408,269)  $(494,368)

 

   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
   For the Three Months Ended September 30, 
   2023   2022 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per share of common stock                    
Numerator:                    
Allocation of net loss including remeasurement of common stock subject to redemption value  $(236,501)  $(171,768)  $(380,410)  $(113,958)
Remeasurement of common stock subject to redemption   662,566    

-

    365,227    - 
Allocation of net income (loss), as adjusted  $426,065   $(171,768)  $(15,183)  $(113,958)
Denominator:                    
Basic and diluted weighted average shares outstanding   4,743,305    3,445,000    11,500,000    3,445,000 
Basic and diluted net income (loss) per share of common stock  $0.09   $(0.05)  $(0.00)  $(0.03)

 

   2023   2022 
  

For the Nine Months Ended

September 30,

 
   2023   2022 
Net income (loss)  $1,224,868   $(294,551)
Remeasurement of common stock subject to redemption   (2,888,960)   (365,227)
Net income (loss) including remeasurement of common stock subject to redemption value  $(1,664,092)  $(659,778)

 

   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
   For the Nine Months Ended September 30, 
   2023   2022 
   Redeemable   Non-redeemable   Redeemable   Non-redeemable 
Basic and diluted net income (loss) per share of common stock                    
Numerator:                    
Allocation of net loss including remeasurement of common stock subject to redemption value  $(1,078,936)  $(585,156)  $(507,691)  $(152,087)
Remeasurement of common stock subject to redemption   2,888,960    -    365,227    - 
Allocation of net income (loss), as adjusted  $1,810,024   $(585,156)  $(142,464)  $(152,087)
Denominator:                    
Basic and diluted weighted average shares outstanding   6,352,042    3,445,000    11,500,000    3,445,000 
Basic and diluted net income (loss) per share of common stock  $0.28   $(0.17)  $(0.01)  $(0.04)

 

11
 

 

Accounting for Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the warrants issued in connection with the Company’s IPO in accordance with the guidance contained in ASC 815 under which the public warrants meet the criteria for equity treatment and the private warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the private warrants as liabilities at their fair value and adjust the private warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants was estimated using a binomial lattice model.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements as of September 30, 2023.

 

Note 3 — Initial Public Offering and Over-allotment

 

Pursuant to the IPO and the over-allotment in December 2021, the Company sold 11,500,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of common stock, one redeemable warrant (each, a “Public Warrant” and collectively, the “Public Warrants”) and one right (each a “Public Right” and collectively, the “Public Rights”). Each Public Warrant entitles its holder to purchase one-half (1/2) of one share of common stock at a price of $11.50 per share, subject to adjustment. Each Public Right entitles the holder to receive one-tenth (1/10) of one share of common stock at the closing of a Business Combination (see Note 8).

 

Note 4 — Private Placement

 

On December 9, 2021 and December 13, 2021, simultaneously with the consummation of the IPO and the underwriters’ exercise of their over-allotment option, the Company consummated the issuance and sale (“Private Placement”) of 570,000 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $5,700,000. Each whole Private Placement Unit consists of one share, one warrant (each a “Private Placement Warrant” and collectively the “Private Placement Warrants”) and one right to receive one-tenth (1/10) of one share of common stock at the closing of a Business Combination. Each whole Private Placement Warrant will be exercisable to purchase one-half of one share of common stock at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and all underlying securities will be worthless.

 

12
 

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On August 19, 2021, the Company’s sponsor purchased 2,875,000 shares (the “Founder Shares”) of the Company’s common stock, par value $0.001, for an aggregate price of $25,000. The Founder Shares are subject to certain transfer restrictions, as described in Note 8.

 

The Initial Stockholders have agreed, subject to limited exceptions, that 50% of these shares will not be transferred, assigned, sold or released from escrow until the earlier of six months after the date of the consummation of the Company’s initial Business Combination and the date on which the closing price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after its initial Business Combination and the remaining 50% of the Founder Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Company’s sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of September 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding.

 

Support Services

 

The Company has entered into an administrative services agreement pursuant to which the Company will pay its sponsor a total of $10,000 per month for office space, administrative and support services. Upon completion of its initial Business Combination or liquidation, the Company will cease paying these monthly fees. As of September 30, 2023 and December 31, 2022, $217,000 and $127,000 respectively, had been accrued under this arrangement and shown under “Due to affiliate” in the accompanying condensed consolidated balance sheets.

 

On September 30, 2023, the Company terminated the administrative services agreement. As a result, the Company will no longer be required to pay the sponsor $10,000 monthly.

 

Advances

 

On each of September 5, 2023 and September 29, 2023, an affiliate of the Sponsor advanced $130,000 to the Company, for a total advance of $260,000. The $260,000 advance to fund trust extension deposits is reflected in “Due to Affiliate” on the condensed consolidated balance sheet.

 

13
 

 

Note 6 — Commitments and Contingencies

 

Registration Rights

 

The holders of Founder Shares, Private Placement Units and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares into shares of common stock) pursuant to a registration rights agreement signed on the date of the prospectus for the IPO. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The underwriters were paid a cash underwriting discount of $0.20 per unit on the offering including the Units issued with the underwriter’s exercise of their over-allotment option, or $2,300,000 in the aggregate at the closing of the IPO. In addition, the underwriters are entitled to deferred underwriting discounts of $0.35 per unit, or $4,025,000 from the closing of the IPO and the exercise of the over-allotment option. The deferred discounts will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes a Business Combination, subject to the terms of the underwriting agreement.

 

Note 7 — Promissory Notes and Advances

 

On March 3, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of $390,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $390,000 had been borrowed and no amount was available under this note for borrowing.

 

On March 23, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of up to $250,000 for working capital needs. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $250,000 had been borrowed and no amount was available under this note for borrowing.

 

On June 2, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of up to $700,000 for working capital needs. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $700,000 had been borrowed and no amount was available under this note for borrowing.

 

For the three and nine months ended September 30, 2023, the notes have incurred $20,265 and $33,376 of interest in connection with the promissory notes and is reflected in the promissory note balance on the unaudited condensed consolidated balance sheet and on the unaudited condensed consolidated statement of operations in other income (expense), respectively. As of September 30, 2023, the total of the promissory notes are reflected on the unaudited condensed consolidated balance sheet as $1,373,376.

 

Note 8 — Stockholders’ Deficit

 

Common stock

 

The Company is authorized to issue 500,000,000 shares of common stock with a par value of $0.001 per share. As of September 30, 2023 and December 31, 2022, there were 3,445,000 (excluding 4,743,305 and 11,500,000 shares of common stock subject to possible redemption, respectively) shares of common stock issued and outstanding.

 

Warrants

 

As of September 30, 2023 and December 31, 2022, the Company had 11,500,000 Public Warrants and 570,000 Private Placement Warrants outstanding.

 

The Public Warrants are accounted for as equity instruments in the Company’s consolidated unaudited condensed financial statements. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of the completion of an initial Business Combination and will expire five years after the completion of an initial Business Combination, or earlier upon redemption. No Public Warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

14
 

 

Redemption of warrants when the price per common stock equals or exceeds $16.50

 

Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the private placement warrants):

 

  in whole and not in part;
  at a price of $0.01 per warrant;
  upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the “30-day redemption period”; and
  if, and only if, the last reported sale price (the “closing price”) of the Company’s common stock equals or exceeds $16.50 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities—Warrants”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of common stock is available throughout the 30-day redemption period. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The Private Placement Warrants are substantially in the same form as the Public Warrants, except they (i) will be exercisable either for cash or on a cashless basis at the holder’s option pursuant and (ii) will not be redeemable by the Company, in either case as long as the Private Placement Warrants are held by the initial purchasers or any of their permitted transferees (as prescribed in the Subscription Agreement, dated December 6, 2021, by and between the Company and Public Gold Marketing Sdn. Bhd). Once a Private Placement Warrant is transferred to a holder other than a permitted transferee, it shall be treated as a Public Warrant for all purposes. Due to these terms the Private Warrants are required to be liability classified.

 

The exercise price and number of shares of common stock issuable on exercise of the warrants may be adjusted in certain circumstances, including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of the warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

 

In addition, if the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 165% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional common stock or equity-linked securities.

 

Rights

 

Except in cases where the Company is not the surviving company in a Business Combination, each holder of a Public Right will automatically receive one-tenth of one share of common stock upon consummation of a Business Combination, even if the holder of a Public Right converted all shares held by him, her or it in connection with a Business Combination or an amendment to the Company’s Second Amended and Restated Certificate of Incorporation with respect to its pre-business combination activities. In the event that the Company will not be the surviving company upon completion of a Business Combination, each holder of a Public Right will be required to affirmatively convert his, her or its rights in order to receive the one-tenth of a share underlying each Public Right upon consummation of the Business Combination.

 

The Company will not issue fractional shares in connection with an exchange of Public Rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Delaware General Corporation Law. As a result, the holders of the Public Rights must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination.

 

15
 

 

Note 9 — Fair Value Measurements

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

 

Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

 

Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

 

As of December 31, 2022, the assets held in the Trust Account were held in money market funds invested in U.S. Treasury Securities. All of the Company’s investments held in the Trust Account are classified as trading securities.

 

The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

      

Quoted Prices in

Active Markets

  

Significant Other

Observable Inputs

  

Significant Other

Unobservable Inputs

 
   Level   (Level 1)   (Level 2)   (Level 3) 
                 
September 30, 2023                    
                     
Liabilities:                    
Warrant Liabilities- Private Warrants   3           $10,716 
                     
December 31, 2022                    
                     
Assets:                    
Money market funds invested in U.S. Treasury Securities   1   $118,408,969         
                     
Liabilities:                    
Warrant Liabilities- Private Warrants   3            6,270 

 

16
 

 

The Private Placement Warrants were valued using a binomial lattice model, which is considered to be a Level 3 fair value measurement. One of the more significant inputs is the implied volatility, which is based on the observed prices of the Company’s common stock and publicly-traded warrants. As of September 30, 2023 and December 31, 2022, the estimated fair value of Warrant Liabilities – Private Warrants were determined based on the following significant inputs and are expressed on the basis of each being exercisable for a one-half of one share of common stock:

 

  

As of

September 30, 2023

  

As of

December 31, 2022

 
Exercise price  $5.75   $5.75 
Market price of public stock  $5.39   $5.10 
Term (years)   0.95    0.8 
Volatility   2.2%   6.9%
Risk-free rate   5.39%   4.69%
Dividend yield   0.0%   0.0%

 

The following table presents the changes in the fair value of warrant liabilities for the three and nine months ended September 30, 2023 and 2022:

 

   Private Placement Warrants 
January 1, 2023  $6,270 
Change in valuation inputs or other assumptions   (570)
Fair value as of March 31, 2023   5,700 
Change in valuation inputs or other assumptions   6,840 
Fair value as of June 30, 2023   12,540 
Change in valuation inputs or other assumptions   (1,824)
Fair value as of September 30, 2023  $10,716 

 

   Private Placement
Warrants
 
January 1, 2022  $114,570 
Change in valuation inputs or other assumptions   (47,367)
Fair value as of March 31, 2022   67,203 
Change in valuation inputs or other assumptions   (42,465)
Fair value as of June 30, 2022   24,738 
Change in valuation inputs or other assumptions   9,462 
Fair value as of September 30, 2022  $34,200 

 

Note 10 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed consolidated financial statements were issued. Based upon this review the Company did not identify any subsequent events, other than the below, that would have required adjustment or disclosure in the consolidated financial statements.

 

On October 5, 2023, Globalink elected to extend the Termination Date by another month until November 9, 2023, and deposited an aggregate of $130,000 into the trust account for its public stockholders. The Extension is fourth of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On October 13, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of $250,000 for the purpose of working capital. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of October 13, 2023, the full $250,000 had been borrowed and no amount was available under this note for borrowing.

 

On October 31, 2023, Globalink elected to extend the Termination Date by another month until December 9, 2023, and deposited an aggregate of $130,000 into the trust account for its public stockholders. The Extension is five of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On October 16, 2023, Globalink received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the “Minimum Total Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Global Market. The Notice states that the Company has 45 calendar days, or until November 30, 2023, to submit a plan to regain compliance with the Minimum Total Holders Rule.

 

17
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this report (this “Quarterly Report”) to “we,” “us,” or the “Company,” refer to Globalink Investment Inc., and when discussing consolidated financial information, also includes Globalink Investment Inc.’s wholly-owned subsidiary, Globalink Merger Sub, Inc., a Nevada corporation. References to our “management,” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to GL Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s latest annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) filed on April 17, 2023. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We were formed on March 24, 2021 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses (the “Business Combination”). Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although we intend to focus our search on target businesses in in North America, Europe, South East Asia, and Asia (excluding China and the special administrative regions of Hong Kong (“Hong Kong”) and Macau (“Macau”)), in the medical technology and green energy industry. We shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau). We intend to complete the business acquisition in a combination of cash (whether cash from the trust account or cash from a debt or equity financing transaction that closes concurrently with the business combination) or our equity securities.

 

The issuance of additional shares of common stock in connection with an initial Business Combination:

 

  may significantly dilute the equity interest of our investors who would not have pre-emption rights in respect of any such issuance;
     
  may subordinate the rights of holders of shares of common stock if we issue shares of preferred stock with rights senior to those afforded to our shares of common stock;
     
  could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
     
  may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and
     
  may adversely affect prevailing market prices for our common stock, rights and/or warrants.

 

18
 

 

    Similarly, if we issue debt securities or otherwise incur significant debt, it could result in:
     
  default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;
     
  acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
     
  our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
     
  our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
     
  using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;
     
  limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
     
  increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
     
  limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and
     
  other purposes and other disadvantages compared to our competitors who have less debt.

 

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

Recent Developments

 

On March 6, 2023, the stockholders of the Company approved an amendment to the Company’s amended and restated certificate of incorporation, allowing the Company to extend the date by which the Company must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses, (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase 100% of the Company’s outstanding public shares of common stock included as part of the units sold in the Company’s IPO (the “Termination Date”) by up to two (2) three-months extensions, followed by three (3) one-month extensions, to December 9, 2023. To obtain each extension, the Company, its sponsor or any of their affiliates or designees must deposit into the Company’s trust account with Continental Stock Transfer & Trust Company, as trustee (“Continental”) by the deadline applicable prior to the extension, $390,000 for each three-month extension and $130,000 for each one-month extension. In connection with the approval of a proposal to amend the Company’s amended and restated certified articles of incorporation which included extending the time in which the Company must complete a Business Combination (the “Extension Amendment Proposal”) and a proposal to amend the Company’s investment management trust agreement (the “Trust Agreement”), originally dated as of December 6, 2021 (the “Trust Amendment Proposal”) at the special meeting held on March 6, 2023, holders of 6,756,695 shares of the Company’s common stock exercised their right to redeem those shares for cash at an approximate price of $10.35 per share, for an aggregate of approximately $69.92 million.

 

On March 6, 2023, Globalink entered into an amendment to the Trust Agreement, originally entered into by and between the Company and Continental on December 6, 2021 to conform the procedures in the Trust Agreement by which the Company may extend the date on which Continental must liquidate its trust account if the Company has not completed its initial business combination to the procedures in the amendment to the Company’s Amended and Restated Certificate of Incorporation.

 

On March 6, 2023, Globalink elected to extend the Termination Date by three months until June 9, 2023, and deposited an aggregate of $390,000 into the trust account for its public stockholders. This extension is first of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On June 1, 2023, Globalink elected to extend the Termination Date by another three months until September 9, 2023, and deposited an aggregate of $390,000 into the trust account for its public stockholders. This extension is second of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On September 7, 2023, Globalink elected to extend the Termination Date by another month until October 9, 2023, and deposited an aggregate of $130,000 into the trust account for its public stockholders. This extension is third of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On October 5, 2023, Globalink elected to extend the Termination Date by another month until November 9, 2023, and deposited an aggregate of $130,000 into the trust account for its public stockholders. This extension is fourth of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

On October 31, 2023, Globalink elected to extend the Termination Date by another month until December 9, 2023, and deposited an aggregate of $130,000 into the trust account for its public stockholders. This extension is five of up to five extensions permitted under the Second Amended and Restated Certificate of Incorporation of the Company.

 

19
 

 

Results of Operations

 

As of September 30, 2023, the Company had not commenced any operations. All activity through September 30, 2023 relates to the Company’s formation and the initial public offering (the “IPO”) and search for a prospective initial Business Combination target. The Company will not generate any operating revenues until after the completion of an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO placed in the trust account established for the benefit of the Company’s public stockholders (the “Trust Account”).

 

For the three months ended September 30, 2023, we had a net income of $254,297, all of which consisted of interest income on cash and investments held in the Trust Account of $621,793 and change in fair value of warrants liabilities of $1,824, partially offset by operating expenses incurred driven by general and administrative expenses of $259,829, provision for income tax of $27,338, accrual of Delaware franchise taxes of $50,000, $20,265 in interest expense and penalties on income tax of $11,888.

 

For the nine months ended September 30, 2023, we had a net income of $1,224,868, all of which consisted of interest income on cash and investments held in the Trust Account of $2,550,909, partially offset by operating expenses incurred driven by general and administrative expenses of $715,665, provision for income tax of $426,710, accrual of Delaware franchise taxes of $133,956, $33,376 in interest expense, penalties on income tax of $11,888 and change in fair value of warrants liabilities of $4,446.

 

For the three months ended September 30, 2022, we had a net loss of $129,141 all of which consisted of operating expenses incurred driven by general and administrative expenses of $580,823, accrual of Delaware franchise taxes of $50,000, provision for income tax of $97,086 and change in fair value of warrants liabilities of $9,462, partially offset by interest income on investments held in the Trust Account of $608,230.

 

For the nine months ended September 30, 2022, we had a net loss of $294,551 all of which consisted of operating expenses incurred driven by general and administrative expenses of $824,303, accrual of Delaware franchise taxes of $150,000, provision for income tax of $97,086, partially offset by interest income on investments held in the Trust Account of $696,468 and change in fair value of warrants liabilities of $80,370.

 

Liquidity, Capital Resources and Going Concern

 

The registration statement on Form S-1 for the Company’s IPO was declared effective on December 6, 2021. On December 9, 2021, we consummated our IPO of 10,000,000 units (collectively the “Units,” each a “Unit”). Each Unit consists of one share of common stock, $0.001 par value, one right to receive one-tenth (1/10) of a share of common stock upon the consummation of an initial Business Combination and one redeemable warrant entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $100,000,000. Simultaneously with the closing of the IPO, we consummated the private placement of 517,500 private units at a price of $10.00 per unit, generating total proceeds of $5,175,000.

 

20
 

 

On December 9, 2021, the underwriters exercised the over-allotment option to purchase an additional 1,500,000 units in full (the “Over-Allotment Units”), and the closing of the Over-Allotment Units occurred on December 13, 2021. The total aggregate issuance by the Company of 1,500,000 Units at a price of $10.00 per Unit resulted in total gross proceeds of $15,000,000. On December 13, 2021, simultaneously with the sale of the Over-Allotment Units, we consummated the private sale of an additional 52,500 private units, generating gross proceeds of $525,000. Since the underwriter’s over-allotment was exercised in full, the Sponsor did not forfeit any insider shares.

 

Offering costs for the IPO and the exercise of the underwriters’ Over-allotment Option amounted to $6,887,896, consisting of $2,300,000 of underwriting fees, $4,025,000 of deferred underwriting fees payable (which are held in the Trust Account) and $562,896 of other costs. The $4,025,000 of deferred underwriting fee payable is contingent upon the consummation of an initial Business Combination by September 9, 2023 (or up until December 9, 2023 if our time to complete a business combination is extended), subject to the terms of the underwriting agreement.

 

Following the closing of the IPO, $116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the IPO (including Over-Allotment Units) and the Private Placement Units was placed in a trust account (“Trust Account”) and was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act.

 

To mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), on August 9, 2023, we instructed the Trustee of the Trust Account to liquidate the U.S. government securities or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash (which may include demand deposit accounts) until the earlier of consummation of our Business Combination or liquidation. Furthermore, such cash is held in bank accounts, which exceed federally insured limits as guaranteed by the Federal Deposit Insurance Corporation (the “FDIC”).

 

For the nine months ended September 30, 2023, cash used in operating activities was $1,174,478. Net income of $1,224,868 was affected by interest earned on cash and investments held in the Trust Account of $2,550,909 and change in fair value of warrants liabilities of $4,446. Changes in operating assets and liabilities reduced $147,117 of cash from operating activities.

 

For the nine months ended September 30, 2022, cash used in operating activities was $576,060. Net loss of $294,551 was affected by interest earned on investments held in the Trust Account of $696,468 and change in fair value of warrants liabilities of $80,370. Changes in operating assets and liabilities provided $495,329 of cash from operating activities.

 

We had cash and investments held in the Trust Account of $51,409,210 and $118,408,969 as of September 30, 2023 and December 31, 2022, respectively. Interest income on the balance in the Trust Account of approximately $0.6 million and $2.6 million for the three and nine months ended September 30, 2023, respectively, may be used by us to pay taxes. Through September 30, 2023, $539,788 was withdrawn from the Trust Account to pay for taxes.

 

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

We had $137,073 and $81,763 of cash held outside of the Trust Account as of September 30, 2023 and December 31, 2022, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete initial Business Combination.

 

In order to finance transaction costs in connection with an initial Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes an initial Business Combination, the Company will repay the working capital loans out of the proceeds of the Trust Account released to the Company. Otherwise, the working capital loans would be repaid only out of funds held outside the Trust Account. In the event that our initial Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the working capital loans, but no proceeds held in the Trust Account would be used to repay the working capital loans. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans. The working capital loans would either be repaid upon consummation of an initial Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such working capital loans may be convertible into units of the post initial Business Combination entity at a price of $10.00 per unit. The units would be identical to the private units. As of September 30, 2023, there were no working capital loans outstanding.

 

On March 3, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of $390,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $390,000 had been borrowed and no amount was available under this note for borrowing.

 

21
 

 

On March 23, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of $250,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $250,000 had been borrowed and no amount was available under this note for borrowing.

 

On June 2, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of up to $700,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $700,000 had been borrowed and no amount was available under this note for borrowing.

 

On each of September 5, 2023 and September 29, 2023, an affiliate of the Sponsor advanced $130,000 to the Company, for a total advance of $260,000. As of September 30, 2023, $260,000 of advance is reflected in “Due to Affiliate” on the condensed consolidated balance sheet.

 

If our initial Business Combination is not consummated, the Company will need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and the Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

 

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 9, 2023 to consummate an initial Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension is not requested by the Sponsor, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur, and an extension is not requested by the Sponsor, and potential subsequent dissolution as well as liquidity condition noted above raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 9, 2023. The Company intends to complete a Business Combination before the mandatory liquidation date.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2023 and December 31, 2022. We do not participate in transactions that create relationships with entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than the below.

 

Registration Rights

 

The holders of the insider shares, the private units and any units that may be issued upon conversion of working capital loans or extension loans (and any securities underlying the private units or units issued upon conversion of the working capital loans or extension loans) will be entitled to registration rights pursuant to a registration rights agreement requiring us to register such securities for resale. The holders of these securities are entitled to make up to two demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act.

 

Underwriting Agreement

 

The underwriters are entitled to a deferred underwriting discounts of $0.35 per Unit, or $4,025,000 from the closing of the IPO. The deferred discounts will become payable to the underwriters from the amounts held in the Trust Account solely if the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.

 

Right of First Refusal

 

Subject to certain conditions, we granted Chardan Capital Markets, LLC, the representative of the underwriters in the IPO, for a period of 18 months after the date of the consummation of our Business Combination, a right of first refusal to act as book-running manager, with at least 30% of the economics, for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement for the IPO.

 

Promissory Notes

 

On March 3, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of $390,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $390,000 had been borrowed and no amount was available under this note for borrowing.

 

On March 23, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of up to $250,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $250,000 had been borrowed and no amount was available under this note for borrowing.

 

22
 

 

On June 2, 2023, the Company entered into a promissory note subscription term sheet with Public Gold Marketing Sdn Bhd for an amount of up to $700,000 for the purpose of extension fees payment. The promissory note bears an interest of 6% per annum and repayable upon consummation of an initial Business Combination. As of September 30, 2023, the full $700,000 had been borrowed and no amount was available under this note for borrowing. As of September 30, 2023, the aggregate amounted owed in connection with the promissory note was $1,373,376, which includes interest accrued as reflected on the unaudited condensed consolidated balance sheet.

 

Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”)

 

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our unaudited condensed consolidated financial statements may not be comparable to companies that comply with public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the consolidated financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.

 

Critical Accounting Policies

 

The preparation of unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

 

Net Income (Loss) Per Share of Common Stock

 

The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share” and uses the two-class method. Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of shares of common stock outstanding for the period. Remeasurement of carrying value to redemption value associated with the redeemable shares of common stock is included in (loss) income per share. As of September 30, 2023 and 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

 

Accounting for Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB, ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own shares of common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the warrants issued in connection with our IPO in accordance with the guidance contained in ASC 815 under which the public warrants meet the criteria for equity treatment and the private warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the private warrants as liabilities at their fair value and adjust the private warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our consolidated statements of operations. The fair value of the warrants was estimated using a binomial lattice model.

 

Temporary Equity

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s shares of common stock sold in the IPO and as a result of the exercise by the underwriters of their over-allotment option features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed consolidated financial statements as of September 30, 2023.

 

23
 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, due to the material weakness identified in the controls related to the events that led to the Company’s restatement of its financial statements to reclassify the Company’s private warrants (complex financial instruments), the Company’s internal control over financial reporting related to our compliance control of timely tax return filings, and due to the revision to our earnings per share for the three and nine months ended September 30, 2022, our disclosure controls and procedures were not effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our unaudited condensed consolidated financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to make disclosures under this Item. We have provided a comprehensive list of risk factors in our annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on April 17, 2023.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

24
 

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

 

Exhibit No.   Description
3.1   Certificate of Incorporation (incorporated by reference to our Form S-1, exhibit 3.1 filed with the Securities and Exchange Commission on November 19, 2021)
3.2   Amended and Restated Certificate of Incorporation (incorporated by reference to our Form 8-K, exhibit 3.1, filed with the Securities and Exchange Commission on December 10, 2021)
3.3   Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.3 of the quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 18, 2023)
3.4   Bylaws (incorporated by reference to our Form S-1, exhibit 3.3 filed with the Securities and Exchange Commission on November 19, 2021)
3.5   Form of Amended and Restated Bylaws. (incorporated by reference to our Form S-1, exhibit 3.4 filed with the Securities and Exchange Commission on November 19, 2021)
4.1   Specimen Unit Certificate (incorporated by reference to our Form S-1, exhibit 4.1 filed with the Securities and Exchange Commission on November 19, 2021)
4.2   Specimen Common Stock Certificate (incorporated by reference to our Form S-1, exhibit 4.2 filed with the Securities and Exchange Commission on November 19, 2021)
4.3   Specimen of Right Certificate (incorporated by reference to our Form S-1, exhibit 4.3 filed with the Securities and Exchange Commission on November 19, 2021)
4.4   Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant (incorporated by reference to our Form S-1, exhibit 4.4 filed with the Securities and Exchange Commission on November 19, 2021)
4.5   Specimen Warrant Certificate (incorporated by reference to our Form S-1, exhibit 4.5 filed with the Securities and Exchange Commission on November 19, 2021)
4.6   Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (incorporated by reference to our Form S-1, exhibit 4.6 filed with the Securities and Exchange Commission on November 19, 2021)
31.1*   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished herewith. In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 herewith are deemed to accompany this Form 10-Q and will not be deemed filed for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act.

 

25
 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GLOBALINK INVESTMENT INC.
     
Date: November 13, 2023 By: /s/ Say Leong Lim
  Name: Say Leong Lim
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)
     
Date: November 13, 2023 By: /s/ Kelvin Chin
  Name: Kelvin Chin
  Title: Chief Financial Officer and Director
    (Principal Financial and Accounting Officer)

 

26